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Abstract 
INTRODUCTION:  
Pulmonary TB is common in South Africa, with many children affected. Diagnosis can be 
challenging and chest x-ray remains fundamental for diagnosis. Interpretation is difficult 
and shown to have wide inter-reader variability. No study however has compared CXR 
findings and inter-reader agreement between ambulatory and hospitalised patients.  
 
AIM:  
This study compares the frequency of CXR changes, as well as inter-reader agreement in 
ambulatory compared to hospitalised children with suspected TB.  
 
METHOD:  
A pre-existing database containing CXR data of children worked up for PTB from 2008-
2013 was used. Retrospective analysis of 69 ambulatory and 112 hospitalised patients, 
aged 0-12 years from Nolungile clinic and Red Cross Children’s Hospital respectively was 
done. Each sample contained 50% proven TB and 50% negative controls. Two paediatric 
radiologists and one paediatrician served as blinded, independent readers for the 
database using standardised tick sheets. 
RESULTS:  
Finding frequency; Fleiss/Free marginal Kappa (ambulatory and hospitalised respectively):  
Overall TB: 27.5% and 35.7%; -0.07 and 0.12 /-0.06 and 0.12 
Parenchymal change: 34.8% and 67.9%; 0.24 and 0.49/0.25 and 0.60 
Lymphadenopathy: 24.6% and 33.9%; 0.01 and 0.13/0.01 and 0.13 
Pleural effusion: 7.3% and 18.8%; 0.27 and 0.61/0.84 and 0.80 
Airway compression: 11.6 and 17.9%; 0.26 and 0.20/0.73 and 0.52 
 
CONCLUSIONS:  
Our study demonstrated no significant difference in lymphadenopathy, but an increase in 
parenchymal change in the hospitalised group. We otherwise showed comparable results 
to literature regarding finding frequency, but poor inter-observer agreement. If the least 
expert reader were removed, results were comparable with available literature. This 
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highlights the need for development and study of explicit CXR criteria for 
lymphadenopathy to improve the value of CXR for paediatric TB in all settings. 
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1. Introduction 
Pulmonary Tuberculosis (PTB) is very common in South Africa, with a large proportion of 
affected individuals being children. Diagnosis can be challenging and chest X-ray (CXR) is a 
fundamental part of the diagnostic algorithm. Interpretation of CXR of children with 
suspected PTB is difficult and findings may depend on factors such as the severity of 
disease and age of the child. Further, radiological signs for diagnosis of PTB using CXR 
have been shown to be subject to wide inter- and intra-observer agreement for the 
diagnosis of PTB in children. In addition the sensitivity and specificity have been poor 
against a strong gold standard(1). 
 
However, the patient selection, or non-selection for these studies may affect the 
outcome. CXR may be more useful for severely ill patients requiring hospitalisation or 
presenting with large airways disease as a result of tuberculous lymphadenopathy, while 
it may be less useful for patients with early PTB or suspected TB infection where it is often 
used as a screening test in patients with a TB contact. 
 
The aim of this study was to compare CXR changes in children with ambulatory disease 
compared to hospitalised patients with confirmed pulmonary TB. 
 
1.1. Epidemiology of TB  
Despite the various preventative and treatment measures in place to combat TB, it still 
represents a significant source of morbidity and mortality globally, with lower than target 
declines in incidence of 1.5% reported in 2015 from 2014(2). While the situation is much 
worse in low or middle income countries (LMICs) such as South Africa (2), the disease has 
also shown increasing incidence in some high income countries such as Denmark over the 
last 20 years, mainly due to immigration (3). A similar situation has been identified in the 
USA with immigrant and adopted children from certain high burden countries showing 
higher risk of TB disease (4). 
 
The majority of TB cases worldwide in 2015 were in LMICs, with six countries accounting 
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for 60% of new cases - India, Indonesia, China, Nigeria, Pakistan and South Africa. Global 
progress in combatting TB depends on advances made in these countries(2).  
The WHO 2016 report estimates South Africa’s TB incidence to be greater than 10000 
new cases per year, one of the highest in the world (2). 
 
Children are one of the groups at highest risk of TB disease. The contribution they make 
to worldwide TB burden is however generally poorly documented, in particular in high 
prevalence countries, due to poor confirmation and reporting of cases(5, 6). According to 
the World Health Organization’s report in 2016, of the 10.4 million new cases of TB 
worldwide, approximately 1.4 million deaths resulted (97000 in South Africa) and  that 
6.3% of new cases of TB occurred in children under 15 years of age (2). In a study done by 
Marais et al in 2006 in South Africa, children aged 13 contributed 13.7% of the total local 
TB burden. Children are therefore an important target population group in the prevention 
and treatment of TB.  In a meta-analysis of 22 high burden LMICs (reported to harbour 
80% of the global burden), the paediatric burden has been estimated to be between 4-
21% of each country’s total burden, significantly higher than the number of 
notifications(6) 
1.2. Pathology/Pathogenesis of TB 
Primary tuberculosis disease begins with the inhalation of M. tuberculosis (TB) bacilli in an 
infectious droplet. This then proceeds to the terminal airways and alveoli and a localized 
pneumonic process occurs, known as the Ghon focus (7).  Lymphatic drainage to 
ipsilateral lymph nodes then causes nodal involvement and lymphadenopathy, which in 
combination with the Ghon focus, as well as in some cases associated pleural thickening, 
is referred to as the Ghon complex (7). 
 
The Ghon complex can then progress to full blown primary pulmonary tuberculosis (PTB), 
as is often seen in older children. However, in most cases infection remains subclinical 
and becomes dormant, as the bacilli are phagocytosed by local macrophages (7). They 
are, however not killed by this process (7). The Ghon focus therefore remains a site of 
possible dissemination and is of importance in cases of so-called ‘reactivation PTB’ (7).  
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Progression of TB can occur via one or more of several routes, including local progression 
from the Ghon focus, via lymphatics and via haematogenous spread (7).  Local 
progression involves penetration through anatomical planes and later caseation and 
cavitation, once the material is discharged into a bronchus (7). This is most commonly 
seen in adults (7). Lymphatic spread is far more common in children under 10 years, 
where lymphobronchial patterns of spread are often seen (7, 8). Children over 10 years of 
age tend to have adult type disease. Haematogenous spread occurs to some degree in all 
cases, with 2 ends of a spectrum identified (7). The first occurs early on with bacilli 
lodging in capillaries and going on to cause disease locally or to further disseminate 
downstream (7).  The second involves erosion into a vessel by more advanced disease and 
subsequent dissemination (7). 
 
PTB is therefore represented by a spectrum of nodal, airway and airspace disease in 
children depending on the degree of each method of spread (7).  
1.3.  Diagnosis of PTB 
The diagnosis of PTB has been based upon a combination of clinical features, positive 
Mantoux test, radiologic investigation and microbiology (9, 10). Diagnosis may be difficult 
in children due to non-specific, variable symptoms and difficulties in making a 
microbiologic diagnosis (11, 12). HIV infection further affects disease pattern, 
complicating diagnosis (12, 13).  Clinical features include cough, fever, loss of weight and 
rarely haemoptysis (9). On history there may be contact with a known TB patient or 
household contact (9).      
 
Mantoux tuberculin skin testing remains important, with one study showing that each 
1mm increase in diameter over the positive threshold represented a 4% increased 
likelihood of a positive sputum culture (14). This has not been confirmed in other studies. 
Mantoux testing can however frequently give false negatives, cannot distinguish between 
exposure versus disease, and BCG vaccine may cause false positives as well (2, 10, 15)   
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The development of tests with increased accuracy in the diagnosis of TB in children are 
vital (11). Currently new tests such as Interferon gamma release assays do not allow for 
the differentiation between active disease and infection (14). Rapid PCR tests such as 
Xpert have become an important part of the diagnostic process in children suspected of 
TB, due to their speed (median 1 vs. 16 days for culture) and higher sensitivity (64%) than 
smear microscopy (10.7%), as well as their ability to detect rifampicin resistance (12).   
However even in optimal settings only 50% of children with clinically diagnosed PTB have 
positive microbiological confirmation using Xpert and culture. 
 
The World Health organization estimated that in 2014, despite many people gaining 
access to effective treatment, up to 37% of new cases were missed (16). In 2016, they 
reported that case fatality rates for TB were over 20% in many African countries, 
compared with as low as 5% in the best performing countries, indicating continued 
inequalities in TB diagnosis and access to treatment(2). Marais et al found that an 
alarming number of severe cases of paediatric TB were being missed on presentation at 
local clinics in Cape Town, South Africa (17). Furthermore, of the missed cases then 
diagnosed at referral centers, most were then hospitalized at TB hospitals due to the 
severity of their disease (17). The fact that so many severely infected children were 
missed serves to underline the great difficulty in the diagnosis of paediatric TB and as 
such, great reliance has fallen onto the role of chest imaging in diagnosis, in particular 
CXR (13, 18, 19). 
 
1.4. Chest X-ray in Paediatric PTB 
CXR is an important part of the diagnosis of PTB in children for the reasons discussed 
above (13, 18, 19). There are however difficulties arising from the differing anatomy such 
as the thymus, and physiology of children (13). Differing radiological techniques are also 
used compared to adults, such as lower dose exposures (13), which may further 
complicate interpretation, especially for less experienced readers. Variation in the quality 
of the films taken may also contribute (13).  
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Further sources of difficulty with the use of CXR for TB diagnosis include effects of 
HIV/AIDS, nonspecific radiographic signs, and inability to assess drug resistance. High cost 
was also noted to be a concern and this is particularly so in the setting of resource-
limited, LMICs such as South Africa where a very high disease burden is found (18). 
 
Chest x-ray features of pulmonary TB in children overlap significantly with those of non-
tuberculous (bacterial, fungal, viral) pneumonia, with few distinguishing features apart 
from the presence of lymphadenopathy (18). The primary feature used in the 
radiographic diagnosis of PTB is therefore the presence or absence of mediastinal 
lymphadenopathy (18-20).  A key factor complicating paediatric TB x-ray diagnosis is the 
absence of standardized, measurable terminology for the spectrum of disease (7).  In 
particular, there are no measurable chest x-ray criteria for stating the presence or 
absence of lymphadenopathy (19).  
1.5 Frequency of findings in paediatric CXR interpretation for TB  
Several studies have reported on the frequency of various CXR findings in paediatric PTB, 
table 1. Only one South African study by Lamont et al that looked specifically at finding 
frequency in 154 laboratory confirmed TB positive children’s CXRs, was found, confirming 
lymphadenopathy as the single most common finding in TB, found in 63% of cases, and 
75% of cases in which the patient was younger than 1 year (21). This was also found to be 
closely associated with localised, patchy consolidation and reticular interstitial 
parenchymal disease, with 91% of patients demonstrating lymphadenopathy, also 
showing these lung changes (21). Miliary pattern was found in (29%), 64% of which were 
less than 1 year of age. 
 
 
 
 
 
 19 
 
Table 1.1: Frequency of findings on CXR for paediatric patients with TB 
Study (year) 
Sample 
size 
Lymphadenopathy Parenchyma 
Pleural 
effusion 
Lamont et al 
(1986) 
154 63% 
Overall – 81% 
Linear interstitial -29% 
Consolidation – 27% 
Miliary – 18% 
12% 
Khatami, et al 
(2008) 
30 90% 
Airspace – 43% 
Reticulonodular and 
miliary – 40% 
6.7% 
Du Toit, Swingler, 
et al (2002) 
100 
Present 18% 
Absent 62% 
Equivocal 20% 
  
Swingler, Du Toit, 
et al (2005) 
100 
47% (overall, incl. 
confident and 
equivocal findings) 
  
 
A second smaller, Iranian study on 30 patients demonstrated a higher prevalence of all 
findings especially lymphadenopathy at 90% (22).  
All publications report the frequency of findings on CXR of known, TB culture positive 
children, which may have led to bias and skewed data compared to real world practice, 
where the imaged patients are unlikely to be confirmed TB. 
 
In their studies on diagnostic accuracy and inter-observer agreement, Du Toit and 
Swingler provide data on the frequency of the finding of lymphadenopathy in their 
studies as well, with the study done in 2002 showing lymphadenopathy in 18% of cases, 
with equivocal findings in 20%. Their study in 2005 combined positive and equivocal 
findings for lymphadenopathy, which were reported in 47% of their study population (18, 
19). 
1.6. Inter-observer agreement in Paediatric CXR interpretation for 
pulmonary TB 
There are relatively few studies that examine reliability through determining the level of 
inter-observer agreement for paediatric chest X-ray diagnosis of TB and/or mediastinal 
lymphadenopathy, table 1.2. 
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Table 1.2: Inter-observer agreement for CXR findings in paediatric patients with TB 
Study (year) Sample size Findings assessed No of readers 
Inter-observer 
agreement (average 
weighted Kappa) 
Intra-observer agreement 
Du Toit, 
Swingler et 
al (2002) 
100 Lymphadenopathy 
4 (paediatric 
pulmonologists) 
0.33 0.55 
Swingler, Du 
Toit et al 
(2005) 
100 Lymphadenopathy 
6 (3 paediatricians and 3 
primary care physicians) 
0.36  
Johnson, 
Kline (2010) 
8 (including 
12 
‘diversion’ 
radiographs) 
Consolidation – any cause 
6 (2 paediatric radiologists, 
2 senior EM physicians, 
and 2 junior paediatric EM 
doctors) 
0.51 (Paediatric 
radiologists) 
0.55 (Senior EM 
physicians) 
0.37 (Junior paediatric 
EM doctors) 
0.87 (Paediatric radiologists) 
0.68 (Senior EM physicians) 
0.62 (Junior paediatric EM 
doctors) 
Xavier-
Souza et al 
(2013) 
803 
Parenchymal change - any 
cause 
2 0.683   
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Both studies by Du Toit and Swingler in 2002 and 2005 demonstrated a low to moderate 
(kappas of 0.33 and 0.36 respectively), by their own categorization, level of inter-observer 
agreement in the detection of lymphadenopathy, amongst experienced observers with an 
interest in TB as well as clinic based primary care doctors.  There was also a lack of 
consistency for individual observers noted i.e. a wide intra-observer variability noted 
between cases, and this was felt to be due to the lack of formal standardized criteria for 
identifying lymphadenopathy on chest x-ray (18). No statistically significant improvement 
in agreement was identified with the use of a lateral view in addition to the standard AP, 
with an estimated 121 lateral views needed to improve detection by one additional case, 
and 74 needed to remove one false positive (19).  
 
Due to the fact that no reference values were used, validity of the observers’ findings 
were not able to be assessed, and the relatively poor level of agreement was felt to be 
due to limitation of chest X-ray as a modality in the detection of paediatric 
TB/lymphadenopathy (19). Weaknesses of the studies include low threshold criteria for 
TB diagnosis, varied expertise in the interpretation of CXR for TB and the lack of 
confirmation of TB by culture. 
 
Despite this relatively low level of agreement, actual levels of agreement in ‘real world’ 
practice may be even lower, (18) especially as the people reporting on CXR findings in 
studies were experienced in diagnosing TB on chest X-ray (18). Therefore, diagnosis of 
paediatric PTB based on the finding of mediastinal lymphadenopathy on chest X-ray, in 
the absence of other supporting clinical features should be made with caution.  
 
Better agreement was noted for the studies dealing with pneumonic changes, likely due 
to the simpler, more clear-cut nature of the findings involved. However agreement levels 
were still only moderate, based on the categorization implemented by Du Toit and 
Swingler (18, 19). 
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1.7. This project in context 
The abovementioned studies on the frequency of CXR findings in paediatric TB include 
only hospitalized children that were microbiologically confirmed TB (21). Both 
abovementioned studies on inter-observer agreement, and the study assessing the 
frequency of CXR findings in TB took place at Red Cross Children’s Hospital in the Western 
Cape province, South Africa, on children admitted with PTB. As this is a referral hospital, 
children would be likely to have severe or more advanced disease. The vast majority of 
PTB cases are, seen at primary clinic level and this therefore, is where most chest x-rays 
will be performed and viewed. As discussed above, in this ‘real world’ setting, finding 
frequency and levels of inter-observer agreement are likely to be lower than reported 
(23). No studies have been published comparing frequency of CXR findings and inter-
observer agreement for the diagnosis of PTB on CXR between a clinic and hospital setting. 
This study aims to compare the CXR findings in children presenting with differing 
severities of microbiologically confirmed PTB i.e. hospitalized vs. ambulatory disease. The 
study investigates the frequency of CXR findings by severity and category of disease as 
well as inter-observer agreement. 
 
 
1.8. Aim 
 
This study aims to compare the frequency of radiological findings as well as the inter-
observer agreement in the diagnosis of paediatric pulmonary TB in ambulatory versus 
hospitalised disease. 
 
The primary endpoint of the study is the comparison of the frequency of overall CXR 
changes in ambulatory compared to hospitalised children with PTB.  
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1.8.1. Study Objectives 
-To compare the frequency of findings on CXR for a hospital as well as an outpatient 
population in children with confirmed PTB 
 
-To investigate the inter-observer agreement for findings on CXR for a hospital as well as 
an outpatient population in children with confirmed PTB 
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2. Materials and Methods 
2.1. Research paradigm 
The study is a secondary analysis of data of paediatric chest x-rays (CXRs) collected as part 
of a prospective study on improved TB diagnosis in children(10, 12).  CXRs were obtained 
at the time of enrolment in the parent study and read by 2 paediatric radiologists as well 
as a paediatrician using a standardised reporting form, in two distinct populations: (a) 
hospital patients and (b) clinic patients. 
2.2. Sample 
The study sample was drawn from previously performed CXRs in paediatric patients 
enrolled in a TB diagnostic study, performed between February 2008 and January 2013 in 
the Western Cape in 2 separate locations: (a) a hospital setting (Red Cross Children’s 
Hospital) in Cape Town, Western Cape and (b) a clinic setting (Nolungile clinic in 
Khayalitsha, Western Cape). Both settings serve populations with similar demographics 
and socioeconomic backgrounds, with Nolungile falling within Red Cross’ drainage area. 
For our study, all microbiologically proven cases of TB from the clinic setting were 
included, with a randomly selected, equal number of non-TB (patients diagnosed with 
non-tuberculous lower respiratory disease) cases as controls for further analyses. A larger 
sample of proven TB cases was randomly selected from the hospitalised group for 
improved statistical power, with an equal number of non-TB/ other respiratory disease 
controls. 
 
2.2.1. Inclusion criteria 
All radiographs read and captured in the existing database of children with suspected TB 
were considered for inclusion in the study.  
Inclusion criteria for this study: 
• Microbiologically confirmed TB 
• Chest X-ray of diagnostic technical quality 
Inclusion criteria for the original study were:  
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• Age younger than 15 years 
• Cough and one of the following:  
o Household TB contact  
o Failure to thrive or loss of weight within the previous 3 months 
o A positive PPD 
2.2.2. Exclusion criteria 
Radiographs reported as inadequate for diagnostic purposes by 2 out of 3 readers, as well 
as those that have incompletely captured data were excluded.  
Exclusion criteria for the main study were: 
• TB treatment/prophylaxis within the preceding 72hrs 
• Inability to be followed up 
• No/Unobtainable consent 
• Sputa (induced or nasopharyngeal) unobtainable 
2.3. Materials and Methods 
CXRs were taken of children with suspected PTB in either a clinic (Nolungile) or hospital 
(Red Cross Children’s Hospital) setting using various X-ray machines with a variety of 
operators. The CXR’s were read by 2 experienced paediatric radiologists and 1 
paediatrician according to a standardised reporting form. The findings of the readers 
were entered onto a tick sheet (Appendix B), and these findings were entered onto an 
Excel spread sheet. 
 
The diagnoses of the patients of whom the films were taken were later confirmed TB 
positive or negative either microbiologically or with Xpert. The readers were blinded to 
any microbiological results, if available, at the time of reading.  
 
The features used in evaluating the CXRs for TB included: 
 
• Parenchymal changes [air-space and nodular] 
• Mediastinal lymphadenopathy 
• Pleural effusion 
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• Airway compression 
 
Examples of chest X-rays with these features are shown in Figure 2.1 
 
The subcategories of the above groups are included in Appendix B, however in our study 
we looked at each group of findings as a whole. Each reader then decided whether the 
CXR was consistent with TB, equivocal/equivocal inconclusive or normal. 
 
Criteria used by the readers for the CXR diagnosis of TB were: 
• Definite radiological TB - defined as the presence of mediastinal lymphadenopathy 
or miliary pattern, regardless of the presence of other findings. 
• Equivocal/Inconclusive – Any positive finding (parenchymal changes or effusion) 
without the presence of the above 2 findings 
• Normal – normal CXR 
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Figure 2.1. Examples of database chest X-rays, with features assessed at reading 
 
 
A: Parenchymal change (Cavitary pneumonia) and lymphadenopathy 
B: Pneumonia and pleural effusion 
C: Lymphadenopathy, airway compression and cavitary pneumonia  
A 
B C 
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2.4. Data collection 
The existing image interpretation data was collected using a pre-developed tick sheet 
detailing each feature evaluated during reading of the films, as well as the diagnostic 
adequacy/quality of the films (Appendix B) and was captured into an Excel spread sheet, 
which was used for this study. 
2.5. Reliability and validity 
Reliability of X-ray interpretation was ensured by using the same 3 readers for the 
evaluation of all radiographs. Readers were blinded to any clinical and laboratory results. 
The use of an appropriately sized sample also addressed reliability. 
Validity of the results was ensured by the use of microbiological confirmation as well as 
the newer Xpert TB test.  CXR is the first line imaging procedure in the diagnosis of TB (18, 
24, 25), and has been found to be a valid test in the screening and diagnosis of TB (26)  
2.6. Bias 
The literature review has been limited to studies done in English, regardless of date up to 
and including May 2017 on Pubmed, using the search terms ‘children’, OR ‘paediatric’, 
‘tuberculosis’ OR ‘PTB’ AND ‘chest x-ray’, which may cause relevant information to be 
missed. Few studies in languages other than English were, however, found on the topics 
searched. All relevant South African studies found were in English and were included. 
 
Bias may have been introduced to the study due to the fact that TB is endemic in the 
study population (Western Cape), as well as the fact that the X-rays are known to be of 
patients with suspected TB. That knowledge may have potentially affected the threshold 
of the readers to ‘call’ a feature that might otherwise be regarded as absent. This is 
partially negated by the fact that this is a true clinical scenario faced by the readers daily 
in clinical practice, as well as by the fact that the readers are experienced and thus will 
have developed their own diagnostic thresholds that should be relatively unaffected as 
compared with a less experienced reader.  
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2.7. Data analysis and statistics 
Based on the prevalence of radiological findings suggestive of TB of 82% in the clinic 
population and 63% in the hospital populations in 2 previous studies using the entire 
dataset (10, 12) and to detect a difference of 22%, in the frequency of the overall CXR 
diagnosis of PTB the minimum sample size necessary for statistical significance was 
determined to be 52 in each of the hospitalised and ambulant groups. 
 
The frequency of overall TB diagnosis as well as each of the above feature groups were 
determined for each population and compared.  
 
The radiological findings and their frequency are summarised by frequency and 
percentage tabulation, and illustrated by means of bar charts.  Continuous variables were 
summarised by the mean, standard deviation, median and interquartile range, and their 
distribution illustrated by means of histograms. 
 
For the CXR outcome, ‘Equivocal//InconclusiveInconclusive’ was grouped with ‘not TB’.   
 
The comparison of gender, HIV status and CXR characteristics between the two patient 
types was carried out using Fisher’s exact test.  The relationship between age and patient 
type and TB status was assessed by the Wilcoxon rank sum test, since the data did not 
meet the assumptions of the independent samples t-test.  The relationship between 
gender and TB status was compared using Fisher’s exact test. 
 
Sensitivity and specificity were compared between the two patient types using the 
clinical/laboratory categories as the gold standard, with the z-test for proportions. 
 
Inter-observer agreement was calculated for the final diagnosis and for each radiological 
feature group of disease presence by Fleiss’ kappa for multiple readers and a binary 
outcome, for each of the population groups (27): 
 
Ƙ̂𝑓 = 1 −
∑ 𝑦𝑖(𝑛𝑖 − 𝑦𝑖)
𝑘
𝑖=1
𝑘𝑛(𝑛 − 1)?̂?(1 − ?̂?)
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Where  
k = number of subjects  
yi = number of positive ratings for subject i 
ni =number of readers for subject I  
?̂? = ∑
𝑦𝑖
𝑛𝑘
𝑘
𝑖=1   
 
Inter-reader reliability between pairs of readers was determined by Fleiss’ chance-
corrected kappa. McNemar’s test and the free-marginal equivalent, Byrt’s PABAK, were 
used to determine inter-reader bias. 
The free-marginal multi-rater kappa was also calculated to address two limitations of 
Fleiss’  kappa, namely its dependence on the prevalence of the feature in question, and 
its assumption that the distribution of the cases amongst the possible categories is fixed. 
 
 
k - values of >0.81 represent almost perfect, 0.61-0.80 substantial, 0.41-0.60 moderate, 
0.21-0.40 fair, 0.01- 0.20 slight and <0.0 less than chance inter-observer agreement.  
The statistical inter-observer agreement was also compared for the two groups.  
 
Data analysis was carried out using SAS v9.4 for Windows.  The 5% significance level was 
used i.e. p-values <0.05 indicate significant results. 
 
3. Results 
There were 82 (41 TB and 41 non-TB controls) ambulatory and 120 (60 TB and 60 non-TB 
controls) hospitalised cases identified in the database. Due to exclusions due to 
inadequate CXR technical quality and reader error (mislabelling, loss of forms) during CXR 
reading, the final included sample was 69 ambulatory and 112 hospitalised cases.   
The number of patients with laboratory confirmed TB in these groups was 31 (44.9%) for 
the ambulatory group with 38 non-TB controls and 56 (50.0%) confirmed TB and 56 non-
TB controls for the hospitalised group.  
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3.1.1. Age, HIV status and Demographics 
3.1.1.1. Age 
 
There was no significant difference in the median age of the hospitalised vs ambulatory 
patients (Wilcoxon rank sum test; p=0.20) with the median age of 37months (IQR 19-
62m;).  The age distributions of overall and for each location are presented in figures 3.1, 
3.2 and 3.3. There was also no significant association between the different age 
stratifications and the radiological diagnosis of TB overall or for either location. This is 
presented in table 3.1. 
 
 
Figure 3.1. Overall Age Distribution 
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Figure 3.2. Age Distribution in TB patients  
 
 
 
Figure 3.3. Age Distribution TB negative patients 
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Table 3.1. Comparison of Age and Lab Proven TB status Overall and by Location 
Age (months) 
p-value for 
between-group test Location N Obs N Mean Std Dev Median Interquartile 
range 
Minimum Maximum 
Overall 181 181 45.5 32.2 36.8 19.2 62.2 2.8 155.5   
 Ambulatory 69 69 43.7 19.3 47.0 27.4 56.2 15.2 88.5 
0.20 
 Hospitalized 112 112 46.6 38.0 33.0 16.6 66.8 2.8 155.5 
TB cases 87 87 45.2 31.4 37.6 18.9 61.4 2.8 143.4   
 Ambulatory 31 31 44.9 18.8 50.8 27.7 56.5 15.2 86.5 
0.30 
 Hospitalized 56 56 45.5 36.8 33.0 16.3 64.6 2.8 143.4 
non-TB cases 94 94 45.7 33.0 36.7 20.1 63.3 3.1 155.5   
 Ambulatory 38 38 42.7 20.0 39.6 24.8 56.2 15.2 88.5 
0.46 
 Hospitalized 56 56 47.7 39.5 34.2 16.8 71.9 3.1 155.5 
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3.1.1.2. Gender 
Overall, there was no significant difference in the gender composition of the two 
locations (Fisher’s exact test; p=0.54); the study group comprised 97 (53.6%) male and 84 
(46.4%) female patients, presented in Table 3.2. There was no significant difference in 
proven TB status between genders, either overall or for ambulatory or hospitalized 
patients, table 3.3. 
 
3.1.1.3. HIV status 
There was no significant difference in the HIV status of patients by location (Fisher’s exact 
test; p=0.30); overall the study group comprised 15.5% HIV-infected patients. These 
results are summarised in Table 3.2. 
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Table 3.2. Gender, HIV and Lab Proven TB status 
Variable Category 
Overall 
 
 
 
Overall TB cases (n=87) non-TB cases(n=94) 
Location   
Overall 
Location   
Overall 
Location   
Ambulatory Hospitalised 
p-
value 
Ambulatory Hospitalised 
p-
value  
Ambulatory Hospitalised 
p-
value  
N   181 69 112   87 31 56   94 38 56   
  n % n % n %   n % n % n %   n % n % n %   
Gender 
Female 84 46.4 30 43.5 54 48.2 
0.54 
38 43.7 13 41.9 25 44.6 
0.83 
46 48.9 17 44.7 29 51.8 
0.53 
Male 97 53.6 39 56.5 58 51.8 49 56.3 18 58.1 31 55.4 48 51.1 21 55.3 27 48.2 
HIV status 
Infected  28 15.5 8 11.6 20 17.9 
0.30 
14 16.1 4 12.9 10 17.9 
0.76 
14 14.9 4 10.5 10 17.9 
0.39 Un-
infected 153 84.5 61 88.4 92 82.1 73 83.9 27 87.1 46 82.1 80 85.1 34 89.5 46 82.1 
Xpert/Cultu
re TB status 
TB 
disease 87 48.1 31 44.9 56 50.0 
0.54 
87 100.0 31 100.0 56 100.0 
  
          
 
  
Non-TB 94 51.9 38 55.1 56 50.0 0 0.0         94 
100.
0 38 
100.
0 56 
100.
0 
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Table 3.3. Comparison of Gender and Lab Proven TB status Overall and by Location 
Gender 
TB status 
TB Non-TB 
p-value for between-group 
test  
 
n % n %   
  Overall 
Female 38 43.7 46 50.0 
0.55 
Male 49 56.3 46 50.0 
  Ambulatory 
Female 13 41.9 17 44.7 
>0.99 
Male 18 58.1 21 55.3 
  Hospitalized 
Female 25 44.6 29 51.8 
0.57 
Male 31 55.4 27 48.2 
 37 
 
3.1.2. Frequency of findings and bias 
3.1.2.1 Comparison of Frequency of Findings 
The frequency of CXR findings, overall and by location (separately for TB cases and non-TB 
controls) are presented in table 3.4 and summarised in figures 3.4, 3.5 and 3.6.  The 
percentage of cases with parenchymal change, and pleural effusion, was significantly 
higher in the hospitalised than the ambulatory group. [TB cases 42(75%) vs 16(51.6%), 
p=0.032; Non-TB controls 34(60.7%) vs 8(21.1%), p=0.0002] There were no significant 
differences between locations for the other features.  Airway compression was present in 
28 (15.5%) patients overall, with 24 of those patients confirmed TB versus only 4 in the 
non-TB controls, as seen in, Table 3.4. There was no significant difference between 
locations. 
 
 38 
 
Table 3.4. Comparison of Finding Frequency Overall and by Location 
V
a
ri
a
b
le
 
Category Overall 
Overall TB cases (n=87) non-TB control (n=94) 
Location   
O
v
e
ra
ll 
Location   
O
v
e
ra
ll 
Location   
Ambulatory 
Hospitalise
d 
p-value Ambulatory 
Hospitalise
d 
p-
value  
Ambulatory 
Hospitalise
d 
p-
value  
n   181 69 112   87 31 56   94 38 56   
  n % n % n %   n % n % n %   n % n % n %   
CXR  
Consistent with 
TB 59 32.6 19 27.5 40 35.7 0.33 42 48.3 15 48.4 27 48.2 
>0.9
9 17 18.1 4 10.5 13 23.2 0.17 
Parenchymal 
change 100 55.2 24 34.8 76 67.9 <0.0001 58 66.7 16 51.6 42 75.0 
0.03
4 42 44.7 8 21.1 34 60.7 
0.00
02 
Airway 
compression 28 15.5 8 11.6 20 17.9 0.30 24 27.6 8 25.8 16 28.6 
>0.9
9 4 4.3 0 0.0 4 7.1 0.14 
Nodes 55 30.4 17 24.6 38 33.9 0.24 39 44.8 13 41.9 26 46.4 0.86 16 17.0 4 10.5 12 21.4 0.26 
Pleural effusion 26 14.4 5 7.2 21 18.8 0.028 22 25.3 5 16.1 17 30.4 0.20 4 4.3 0 0.0 4 7.1 0.14 
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Figure 3.4. Frequency CXR Findings Overall 
 
 
Figure 3.5. Frequency of CXR findings in confirmed TB cases 
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Figure 3.6. Frequency of CXR findings in non-TB cases 
 
3.1.2.2. CXR diagnosis of TB 
The frequency of X-ray diagnosis of TB according to each reader and for ambulatory and 
hospitalised groups is summarised below in table 3.5. Reader C stands out as having 
identified a higher proportion of the patients as having a CXR with TB, compared to the 
other readers (as well as to the true, microbiologically confirmed value).  Conversely, the 
other two readers have identified a lower proportion of patients as having a CXR with TB, 
compared to the true value. 
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Table 3.5. Frequency of CXR diagnosis of TB 
 
 
 
 
 
 
 
  
Inter-observer agreement and bias for CXR diagnosis of TB is summarised in table 3.5 
below. The raw agreement between all three readers was 20.3% and 33.9% for the 
Ambulatory and Hospitalised groups respectively. 
 
The Fleiss’ kappa chance-corrected measure of agreement was -0.07 (Ambulatory) and 
0.12 (Hospitalised), which corresponds to ‘less than chance’ and ‘slight’ agreement 
respectively.  The respective  free-marginal kappas were -0.06 (Ambulatory) and 0.12 
(Hospitalised), again corresponding to ‘less than chance’  and ‘slight’ agreement. 
 
Inter-reader bias was tested using Cochran’s Q statistic.  This was significant (p<0.0001) 
for both locations, indicating significant bias between the readers in determining the 
presence / absence of TB from the CXR. 
 
For each pair of readers, the cross-tabulation of ratings, the chance-corrected kappa and 
the test for inter-reader bias (McNemar’s test for two readers) are summarised in table 
3.6. 
 
Of note, is that reader C is rating significantly differently to the other readers for both 
locations. If C were to be removed, the agreement for the other 2 readers (both 
experienced paediatric radiologists) was k=0.53 and 0.33 for the hospitalised and 
ambulatory groups respectively, which compares much more favourably with the 
literature.   
Reader 
% patients with TB (number) 
ambulatory (n=69) hospitalised (n=112) 
Culture/Xpert 
proven TB 44.9 (31) 50.0 (56) 
A 27.5 (19) 35.7(40) 
B 18.8(13) 30.4(34) 
C 89.9(62) 74.1(83) 
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The ratings therefore cannot be combined to give a majority decision rating, as this would 
be statistically equivalent to randomly generating the majority decision for each case.    
 
If reader C were to be removed, a majority decision cannot be calculated, as there would 
only be 2 readers left.   
 
It was therefore concluded that a majority decision cannot be created out of the data 
available and it was decided to use the ratings of the single most experienced reader (A) 
for the finding frequency analyses, as well as sensitivity and specificity. 
 
Examples of chest X-rays of the Ambulatory and Hospitalised patients with agreement for 
each are given in Figure 3.7 and Figure 3.8. 
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Figure 3.7. Examples of chest X-rays of the Hospitalised group 
  
A: Hospital patient with lab proven TB. Good inter-reader 
agreement for lymphadenopathy, parenchymal disease and overall 
diagnosis of PTB. 
B: Hospital patient with lab proven TB. Poor inter-reader 
agreement for lymphadenopathy and overall diagnosis of PTB. 
C: Clinic patient without TB disease. Poor agreement on the 
presence of lymphadenopathy and the overall diagnosis. 
A 
B 
C 
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Figure 3.8. Examples of CXR’s of the Ambulatory group 
B 
A 
B 
C C 
A: Clinic patient with lab proven TB. Good inter-reader agreement 
for lymphadenopathy and overall diagnosis of PTB. 
B: Clinic patient with lab proven TB. Poor inter-reader agreement for 
lymphadenopathy and overall diagnosis of PTB. 
C: Clinic patient without TB disease. Poor agreement on the 
presence of lymphadenopathy and the overall diagnosis. 
 45 
 
Table 3.6. Inter-observer agreement and bias for CXR diagnosis of TB 
Location Raters Fleiss’ kappa Interpretation of kappa Free-marginal kappa interpretation of kappa p-value  
Ambulatory 
Overall -0.07 less than chance agreement -0.06 less than chance agreement <0.0001 
A vs B 0.44 moderate agreement 0.59 moderate agreement 0.11 
A vs C 0.04 slight agreement -0.30 less than chance agreement <0.0001 
B vs C 0.01 slight agreement -0.48 less than chance agreement <0.0001 
Hospitalised 
Overall 0.12 slight agreement 0.12 slight agreement <0.0001 
A vs B 0.32 fair agreement 0.39 fair agreement 0.30 
A vs C 0.17 slight agreement 0.05 slight agreement <0.0001 
B vs C 0.08 slight agreement -0.09 less than chance agreement <0.0001 
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3.1.2.3. Parenchymal change 
The frequency of parenchymal change as recorded individually by the three readers is 
summarised in table 3.7 below. Reader C again stands out as having identified a higher 
proportion of the patients as having parenchymal change in both groups.  
Table 3.7. Frequency of Parenchymal change 
Reader 
% patients with Parenchymal 
change(number) 
ambulatory (n=69) hospitalised (n=112) 
A 34.8 (24) 67.9 (76) 
B 37.7 (26) 69.6 (78) 
C 68.1 (47) 81.3 (91) 
 
 
Agreement:   
The raw agreement between all three readers was 43.5% and 69.6% for the Ambulatory 
and Hospitalised groups respectively. This is summarised in table 3.8 below. 
 
The Fleiss’ kappa chance-corrected measure of agreement was 0.24 (Ambulatory) and 
0.49 (Hospitalised), which corresponds to ‘fair’ and ‘moderate’ agreement respectively. 
The respective free-marginal kappas were 0.25 (Ambulatory) and 0.60 (Hospitalised), 
which again corresponded to ‘fair’ and ‘moderate’ agreement. 
 47 
 
Table 3.8. Inter-observer agreement and bias for Parenchymal change on CXR 
 
Location Raters Fleiss' kappa interpretation of kappa Free-marginal kappa interpretation of kappa p-value  
Ambulatory 
Overall 0.24 fair agreement 0.25 fair agreement <0.0001 
A vs B 0.56 moderate agreement 0.59 moderate agreement 0.59 
A vs C 0.24 fair agreement 0.16 slight agreement <0.0001 
B vs C 0.07 slight agreement -0.01 less than chance agreement 0.0004 
Hospitalised 
Overall 0.49 moderate agreement 0.60 moderate agreement 0.0029 
A vs B 0.71 substantial agreement 0.75 substantial agreement 0.59 
A vs C 0.33 fair agreement 0.48 moderate agreement 0.0053 
B vs C 0.41 moderate agreement 0.55 moderate agreement 0.0093 
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Inter-reader bias: 
The inter-reader bias was significant for both groups (p<0.0001 and 0.0029 for 
Ambulatory and Hospitalised, respectively), indicating significant bias between the 
readers in determining the presence / absence of parenchymal change.   
 
For both locations, reader C is rating significantly differently to the other readers. 
The agreement between the remaining two readers is k=0.56 and 0.71 for the Ambulatory 
and Hospitalised groups respectively. 
 
3.1.2.4. Lymphadenopathy 
The frequency of lymphadenopathy on CXR as recorded by the individual readers is 
summarised in table 3.9 below. Reader C again stands out as having identified a higher 
proportion of the patients as having lymphadenopathy in both groups, compared to the 
other readers. 
Table 3.9. Frequency of Lymphadenopathy on CXR 
Reader 
% patients with 
Lymphadenopathy(number) 
ambulatory (n=69) hospitalised (n=112) 
A 24.6(17) 33.9(38) 
B 24.6 (17) 40.2 (45) 
C 89.9 (62) 75.9 (85) 
 
 
 
Agreement:   
The raw agreement between all three readers was 26.1% and 34.8% for the Ambulatory 
and Hospitalised groups respectively. This is summarised in table 3.10 below. 
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The Fleiss’ kappa chance-corrected measure of agreement was 0.01 (Ambulatory) and 
0.13 (Hospitalised), which corresponds to ‘slight’ agreement in both cases. The 
corresponding free-marginal kappas were identical.
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Table 3.10. Inter-observer agreement and bias for Lymphadenopathy on CXR 
Location Raters Fleiss’ kappa interpretation of kappa Free-marginal kappa interpretation of kappa p-value  
Ambulatory 
Overall 0.01 slight agreement 0.01 slight agreement <0.0001 
A vs B 0.53 moderate agreement 0.65 substantial agreement >0.99 
A vs C 0.07 slight agreement -0.30 less than chance agreement <0.0001 
B vs C 0.07 slight agreement -0.30 less than chance agreement <0.0001 
Hospitalised 
Overall 0.13 slight agreement 0.13 slight agreement <0.0001 
A vs B 0.33 fair agreement 0.38 fair agreement 0.24 
A vs C 0.19 slight agreement 0.05 slight agreement <0.0001 
B vs C 0.06 slight agreement -0.04 less than chance agreement <0.0001 
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Inter-reader bias: 
The inter-reader bias was significant for both groups (p<0.0001 for both groups), 
indicating significant bias between the readers in determining the presence / absence of 
lymphadenopathy.   
 
For both locations reader C is rating significantly different.   
If reader C were to be excluded, the agreement between the remaining two readers is 
k=0.53 and 0.33 for Ambulatory and Hospitalised groups respectively. 
 
3.1.2.5. Pleural Effusion 
The frequency of pleural effusion by each individual reader is summarised in table 3.11 
below. Reader C does not rate significantly differently from the other readers for this 
feature. 
Table 3.11. Frequency of Pleural Effusion on CXR 
 
Reader 
% patients with Pleural effusion (number) 
ambulatory (n=69) hospitalised (n=112) 
A 7.3 (5) 18.8 (21) 
B 1.5 (1) 12.5 (14) 
C 7.3 (5) 14.3 (16) 
 
Agreement:   
The raw agreement between all three readers was 88.4% and 84.8% for the Ambulatory 
and Hospitalised groups respectively. This is summarised in table 3.12. below. 
 
The kappa chance-corrected measure of agreement was 0.27 (Ambulatory) and 0.61 
(Hospitalised), which corresponds to ‘fair’ and ‘substantial’ agreement respectively. The 
respective free-marginal kappa measures of agreement were 0.84 (Ambulatory) and 0.80 
(Hospitalised), which corresponded to ‘almost perfect’ agreement in both cases.   
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Table 3.12. Inter-observer agreement and bias for Pleural Effusion on CXR 
 
Location Raters Fleiss' kappa interpretation of kappa Free-marginal kappa interpretation of kappa p-value  
Ambulatory 
Overall 0.27 fair agreement 0.84 almost perfect agreement 0.10 
A vs B 0.32 fair agreement 0.88 almost perfect agreement 0.046 
A vs C 0.35 fair agreement 0.83 almost perfect agreement >0.99 
B vs C 0.32 fair agreement 0.88 almost perfect agreement 0.046 
Hospitalised 
Overall 0.61 substantial agreement 0.80 almost perfect agreement 0.10 
A vs B 0.63 substantial agreement 0.80 almost perfect agreement 0.035 
A vs C 0.52 moderate agreement 0.73 substantial agreement 0.20 
B vs C 0.69 substantial agreement 0.86 almost perfect agreement 0.48 
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Inter-reader bias: 
The inter-reader bias was not significant for the either group (p=0.10 for both groups).   
 
Although there was no significant inter-reader bias at overall level for the Ambulatory 
group, the pairwise comparisons suggest that the ratings from B could be different to 
those of the other two readers and although there was also no significant inter-reader 
bias at overall level for the Hospitalised group, the pairwise comparisons suggest that the 
ratings from A and B were significantly biased. 
 
3.1.2.6. Airway Compression 
The frequency of airway compression on CXR as recorded by the individual readers is 
summarised in table 3.13 below. In this case Reader C has identified a lower proportion of 
patients as having airway compression compared with the other readers. 
Table 3.13. Frequency of Airway Compression on CXR 
Rater 
% patients with Airway compression 
ambulatory (n=69) hospitalised (n=112) 
A 11.6 17.9 
B 15.9 25.9 
C 2.9 10.7 
 
Agreement: 
The raw agreement was 79.7% and 64.3% for the Ambulatory and Hospitalised 
groups respectively, summarised in Table 3.14 below. 
 
The Fleiss’ kappa chance-corrected measure of agreement was 0.26 (Ambulatory) and 
0.20 (Hospitalised), which corresponds to ‘fair’ agreement in both cases.  
The corresponding free-marginal kappa measures of agreement were 0.73 
(Ambulatory) and 0.52 (Hospitalised), which corresponded to ‘substantial’ and 
‘moderate’ agreement respectively.  Here the difference between the two sets of 
kappa coefficients is evident as the Fleiss’ (fixed-marginal) kappa is affected by the 
relatively low prevalence of airway compression. 
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Inter-reader bias: 
The inter-reader bias was significant for both groups (p=0.011 and 0.0044 for 
Ambulatory and Hospitalised groups respectively), indicating significant bias between 
the raters in determining the presence / absence of airway compression.   
 
For the Ambulatory group, it is clear that reader C is reading differently compared to 
the other two readers.   
 
Although the free-marginal kappas appear better than the Fleiss’/fixed-marginal 
kappas (due to low-prevalence), the inter-reader bias remains, and complicates 
attempts to draw conclusions from the kappa values. 
 
In the Hospitalised group, although there was significant inter-reader bias, there is no 
single reader at fault – the ratings are simply disparate. 
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Table 3.14. Inter-observer agreement and bias for Airway Compression on CXR 
Location Raters Fleiss' kappa interpretation of kappa Free-marginal kappa Interpretation of kappa 
p-value for Cochrane's Q / 
McNemar's test 
Ambulatory 
Overall 0.26 fair agreement 0.73 substantial agreement 0.011 
A vs B 0.33 fair agreement 0.68 substantial agreement 0.37 
A vs C 0.16 slight agreement 0.77 substantial agreement 0.034 
B vs C 0.27 fair agreement 0.74 substantial agreement 0.0027 
Hospitalised 
Overall 0.20 fair agreement 0.52 moderate agreement 0.0044 
A vs B 0.35 fair agreement 0.55 moderate agreement 0.072 
A vs C 0.13 slight agreement 0.57 moderate agreement 0.10 
B vs C 0.11 slight agreement 0.45 moderate agreement 0.0023 
 
 52 
 
 
 
3.1.3. Sensitivity and Specificity 
The sensitivity and specificity of CXR for the detection of TB for each location, are shown 
in table 3.15.  The values in parentheses denote the 95% confidence interval for the 
estimate (the confidence intervals are very wide due to the small sample size). 
Table 3.15. Sensitivity and Specificity of CXR (Reader A) for the diagnosis of TB  
  ambulatory (n=69) hospitalised (n=112) 
Sensitivity (%) 48.4 (30.2-66.9) 48.2 (34.7-62.0) 
Specificity (%) 89.5 (75.2-97.1) 76.8 (63.6-87.0) 
 
Sensitivity was lower than specificity for both locations.  
There was no significant difference in the sensitivity or specificity between the two 
locations (p=0.99 and 0.12 respectively). 
 
4. Discussion 
4.1. Results in context 
Our study was consistent with the literature in demonstrating lymphadenopathy as the 
most common extra parenchymal manifestation of pulmonary TB in children, but did not 
show a significant difference its frequency between the ambulatory and hospitalised 
groups. There was however a significantly higher frequency of less specific findings 
(parenchymal change and pleural effusions) in the hospitalised group. Overall agreement 
between readers was poor, however with the least experienced reader removed, 
agreement between the remaining two readers compared more favourably with 
literature.  
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4.1.1 TB 
Pulmonary tuberculosis remains a major public health problem in the Cape Town area, 
with the drainage areas of Red Cross Children’s Hospital and Nolungile clinic being 
amongst the worst affected (21). 
Due to a number of factors including a poorly developed immune response, most cases of 
pulmonary tuberculosis cases seen in infants and young children are due to primary 
infection (22). Our study findings are consistent with this, with hilar and mediastinal 
lymphadenopathy being the most common specific finding for TB.  
The high rate of parenchymal lung changes in our study and in particular in the 
hospitalised group, most of which are severe and non-specific is also consistent with 
literature which states that PTB in children is a potentially more serious disease with a 
higher risk of severe complications than in adults (22). Treatment should therefore begin 
on suspicion, rather than on culture confirmation as therapy is rapidly effective, and 
potentially lifesaving (21, 22). 
 
Diagnosis of PTB in children is difficult, imprecise and is confirmed in no more than 40% of 
cases due to difficulty in sputum production and sampling, with a large number of the 
children in our database never receiving microbiological confirmation (and thus were not 
eligible for inclusion) and requiring empiric treatment on clinical and CXR grounds. 
Further investigations such as CXR are therefore very important. 
 
4.1.2 CXR 
In the paediatric age group the chest radiograph (CXR) is of major importance in early 
diagnosis due to the aforementioned difficulties with bacteriological confirmation (9, 18, 
21, 22) 
Computerized tomography (CT) with contrast injection is regarded as more accurate than 
CXR in detecting lymphadenopathy and is the current gold standard for detection, with 
significantly better sensitivity and specificity than we found in our study (9, 18, 22).  
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In a clinic setting however CT is not easily available and attempts to utilize it routinely 
would only further delay diagnosis due to long referral processes and waiting times. 
Even in settings where CT is readily available, attempts should be made to define and 
improve the accuracy of chest radiography, given its faster turn-around time, lower 
radiation dose, lower cost and the lack of need for contrast injection compared with CT 
(9, 18, 22). 
 
4.1.3 Overall TB and Feature frequency and agreement 
 
The frequency of overall TB diagnosis by CXR could not be determined by majority 
decision for the reasons outlined in section 3.1.2.2. The overall frequency of TB diagnosis 
on CXR by the most experienced reader, Reader A, was 27.5% and 35.7%, compared with 
the microbiologically proven TB positive values of 44.9% and 50% for ambulatory and 
hospitalised patients respectively. As expected, these results correlated best with the 
patients’ actual, XPert/culture proven TB status of all 3 readers. 
 
Our study shows significantly higher frequency of parenchymal change and pleural 
effusion in the hospitalised patients for both confirmed TB and non-TB patients with 
other respiratory disease, compared with the ambulatory group. This most likely relates 
to increased severity of disease in the TB positive cases and the presence of other 
organisms in the non-TB patients causing their symptoms and thus admission.  
 
The lack of a significant difference in the frequency of lymphadenopathy between the 
hospitalised ambulatory groups may relate to lymphadenopathy being difficult to detect 
on CXR until large; further large nodes are not always associated with airway compression 
and erosion or clinically severe disease, as evidenced by the low prevalence of airway 
compression relative to nodes in our study. In the non-TB patients, lymphadenopathy is 
not expected to be a major/common feature of disease and thus a significant difference 
between the hospitalised and ambulatory groups is not expected. 
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Despite the lack of statistical significance, of interest is the trend toward better 
agreement on the presence of lymphadenopathy and the overall diagnosis of TB in the 
ambulatory group, particularly between readers A and B. This is contrary to our initial 
hypothesis and may indicate that the more severe parenchymal change in the 
hospitalised group could obscure more specific findings of TB. 
Airway compression was present in a higher number of TB versus non-TB patients, which 
is expected given its relationship with the presence of nodes. Although not reaching 
statistical significance, a higher number of hospitalised TB patients also demonstrated 
airway compression relative to ambulatory TB patients. 
 
The poor and/or statistically insignificant agreement between readers along with the 
degree of bias found, does however call into question the reliability of the findings by 
some of the readers, and opens up new avenues for study on attempts at maximizing the 
sensitivity and specificity for the detection of TB on this modality through the 
development of clear criteria regarding the presence or absence features of TB, as well as 
comparing CXR with CT, which is the gold standard (18, 20). 
 
4.1.4. Comparison of Finding Frequency (most experienced reader – Reader A) 
with the Literature 
 
The available literature concerns only hospitalised patients with confirmed TB and is 
summarised in Table 4.1. 
Our findings regarding the frequency of lymphadenopathy in both ambulatory and 
hospitalised patients with confirmed TB are comparable with those found by Swingler et 
al in their 2005 study in the same region. The lower overall frequency of 
lymphadenopathy in our study can be attributed to the presence of TB negative controls.  
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Table 4.1. Comparison of Frequency of findings on CXR with literature 
Study (year) Sample size Lymphadenopathy Parenchymal change Pleural effusion 
  Amb Hosp Amb Hosp Amb Hosp 
Our study (overall) 181 24.6% 33.9% 34.8% 67.9% 7.3% 18.8% 
Our study (confirmed TB)  87 41.9% 46.4% 51.6% 75% 16.1% 30.4% 
Lamont et al (1986) 154 63% 81% 12% 
Kim et al (2006) 25 96% 72%  
Khatami et al (2008) 30 90% 83.3% 6.7% 
Du Toit, Swingler, et al (2002) 100 
Present 18% 
Absent 62% 
Equivocal 20% 
  
Swingler, Du Toit, et al (2005) 100 
47% (overall, incl. confident and 
equivocal findings) 
  
Key: Amb = ambulatory; Hosp = Hospitalised
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The remaining studies demonstrate a higher percentage of lymphadenopathy in the case 
of Khatami et al, Kim et al and Lamont et al, while Du Toit et al found a lower percentage. 
These differences may be due to differing levels of reader experience, differing reader 
criteria for the detection of lymphadenopathy and demographic/regional differences. In 
the case of Khatami et al and Kim et al, differences may be due to the very small sample 
size in these studies. Incidences reported in Nigeria were 17% and 59% in Korean children 
(21) 
Lymphadenopathy was however still the most common extra-parenchymal manifestation 
of TB in all the reviewed studies, a result which is consistent with ours and important in 
the clinical setting due to this finding being the most specific for the diagnosis of TB on 
CXR (18, 19, 21, 22). 
 
Our ambulatory group demonstrated 51.6% of patients with parenchymal change on CXR, 
which is likely due to the earlier/less severe disease expected in most clinic presentations. 
In our hospitalised group however, our study found parenchymal involvement in 75% of 
TB patients, similar to the 81% and 83% found by Lamont et al and Khatami et al 
respectively, but lower than the 96% found by Kim et al. Again, the small sample size used 
by Kim et al may be the reason for this. The differential in parenchymal change between 
ambulatory and hospitalised patients warrants further study, with exploration of the 
varying subtypes of parenchymal change found, which was outside of the scope of this 
study. 
 
Pleural effusion is not a common feature of primary pulmonary tuberculosis in young 
children, and is rare in infants (15). This is confirmed by the results shown by Lamont et al 
and Khatami et al.  Our study however showed a higher percentage of pleural effusion, 
the reason for which is unclear. Further study is however needed in our South African 
setting, to determine whether pleural effusion may have a larger than previously known 
role in distinguishing between paediatric pneumonia and PTB. 
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4.1.5. Comparison of Inter-observer agreement for CXR findings with literature 
 
Comparison of inter-observer agreement with the available literature is summarised in 
table 4.2. 
 
Du Toit et al concluded that lymphadenopathy could be detected on chest radiography 
with fair inter-observer agreement (18). Our study however demonstrated very poor 
inter-observer agreement for this feature. Factors that may have influenced this include 
the fact that our study, unlike those of Swingler et al and Du Toit et al, included both 
laboratory confirmed TB and non-TB patients. As such our study may better represent 
actual real-world results for a TB endemic area. A further influence on our study is the 
fact that one of our readers, C (a clinician), read consistently and significantly differently 
from our other two, more expert/experienced readers. If C were removed, the agreement 
for the other 2 readers (both experienced paediatric radiologists) compares more 
favourably with the literature.  
For parenchymal change, our level of agreement overall compares favourably with those 
of Johnson et al, but are lower than that reported by Xavier-Souza et al. If reader C is 
again removed, the agreement for the other 2 readers is k=0.56 and 0.71 for ambulatory 
and hospitalised patients respectively. This compares more favourably with Xavier-Souza 
et al. 
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Table 4.2: Comparison of Inter-observer agreement for CXR findings with literature 
Study (year) Sample size Findings assessed No of readers 
Inter-observer 
agreement (average 
weighted Kappa) 
Inter-observer 
agreement for our study 
overall/Reader A and B 
only (for the equivalent 
feature)  
 Amb Hosp 
Du Toit, 
Swingler et al 
(2002) 
100 Lymphadenopathy 
4 (paediatric 
pulmonologists) 
0.33 
0.01/0.53 0.13/0.33 
Swingler, Du 
Toit et al 
(2005) 
100 Lymphadenopathy 
6 (3 paediatricians and 3 
primary care physicians) 
0.36 
Johnson, Kline 
(2010) 
8 Consolidation – any cause 
6 (2 paediatric 
radiologists, 2 senior EM 
physicians, and 2 junior 
paediatric EM doctors) 
0.51 (Paediatric 
radiologists) 
0.55 (Senior EM 
physicians) 
0.37 (Junior 
paediatric EM 
doctors) 
0.24/ 0.56 0.49/0.71 
Xavier-Souza 
et al (2013) 
803 
Parenchymal change – any 
cause 
2 0.683  
Key: Amb = ambulatory; Hosp = Hospitalised
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For pleural effusion, our readers show Fleiss‘ kappa values of 0.27 for the ambulatory and 
0.61 for hospitalised patients. These represent fair and substantial agreement 
respectively, but in this instance the statistical measures are flawed due to the low 
prevalence of pleural effusion. The free-marginal kappa values of 0.84 (Ambulatory) and 
0.80 (Hospitalised), which corresponded to ‘almost perfect’ agreement in both cases, 
demonstrated more accurately the true level of agreement for this feature in our study. 
Pleural effusion is however an infrequent and non-specific feature of primary TB and, on 
its own, of little help in the CXR diagnosis of TB. Furthermore, the literature with which 
we are comparing results use Fleiss’ kappa, making this a more appropriate comparative 
measure. 
The issue of reader C rating so differently from the other 2 more experienced readers 
highlights a concern for real world use of CXR for the diagnosis of TB in that the expertise 
and experience of the readers so vastly affects the interpretation. In a clinic setting 
doctors of widely varying experience interpret CXR’s for TB. Their experience and 
expertise in CXR interpretation will however invariably be less than that of qualified 
paediatric radiologists and far poorer levels of agreement can be expected. This may be 
less of an issue in a setting such a Red Cross Children’s’ Hospital, where studies are 
routinely reported by paediatric radiologists, however a similar, if less marked, difference 
in expertise can be expected in lower level, less specialised hospital settings where only a 
general radiologist may be available. 
Sensitivity and Specificity 
Our study showed no significant difference in sensitivity or specificity for the diagnosis of 
TB on CXR between the Ambulatory and Hospitalised groups. This goes against our 
hypothesis that the hospitalised patients would demonstrate more severe changes and 
therefore be more reliably diagnosed on X-ray. It does however correlate well with our 
findings of no significant difference in the frequency of the most specific CXR feature, 
lymphadenopathy, between the 2 groups. The hospitalised group did indeed show 
increased frequency of parenchymal change and pleural effusion, but unfortunately these 
features have considerable overlap with other chest pathologies and are thus much less 
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specific for TB.  If only 2 readers (A and B) are considered, there is however better 
reliability within the hospitalised group, suggesting that for more expert readers at least, 
CXR signs may be more easily agreed upon in these sicker patients. 
 
Sensitivity was lower than specificity for both locations. This is unfortunate in the context 
of our study, as, even with the most experienced reader, whose results were used for the 
generation of sensitivity and specificity, approximately half of the cases that presented 
would go undiagnosed on the basis of CXR alone. 
 
A normal CXR therefore cannot exclude the presence of PTB in children. When present 
however, the radiographic findings, although not commonly specific for PTB, reflect the 
pathological changes taking place and greatly assist in diagnosis and treatment decisions 
(21). 
 
4.2. Current applications  
Despite the fact that in the diagnosis of paediatric pulmonary TB, CXR is commonly the 
single most useful investigation, our study as well as the available literature demonstrates 
that the absence of any abnormality can be misleading (21). 
Our study therefore supports the current clinical practice of using CXR as an adjunctive 
investigation along with clinical and laboratory evaluation. If the CXR is normal however 
and there is the suspicion of TB, the clinician should not cease the search for the disease, 
but should rather turn to more advanced investigations such as CT or MRI for clarification. 
Newer laboratory investigations such as Xpert have been shown to improve detection 
from the poor sputum and gastric lavage yields in children and should also be used as far 
as possible, as currently no single investigation demonstrates acceptable sensitivity and 
specificity and adequate diagnostic accuracy can currently only be achieved using a 
combination of the above. 
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4.3. Limitations of the current study 
Limitations of our study include a relatively small sample size due to the relative scarcity 
of microbiologically confirmed TB patients available within the database, as well as the 
need to have all CXR’s read by all 3 readers.  
 
Bias was shown to be a significant problem in our study (except for pleural effusion) and 
likely relates to the readers knowing that the CXR’s were being assessed specifically for 
TB, as well as the fact that the study was being done in a region and population with 
endemic TB (12, 21). This is difficult to address and eliminate. A similar bias can also be 
expected in practicing clinicians in the region. The effect of this degree of bias may be an 
area for further study. 
 
The database utilised also included multiple subgroups for each of the CXR features 
groups (parenchymal, lymphadenopathy, effusion), allowing for more in depth analysis of 
the frequency and agreement each feature group. This was however deemed beyond the 
scope of the current study. 
 
A further limitation is the inclusion of CXRs read as inconclusive as normal for the purpose 
of analysis. This is due to the fact that in a practical, clinical setting an inconclusive CXR is 
unhelpful in the diagnosis or exclusion of TB. Further study and more in-depth analysis of 
inconclusive CXRs along with the abovementioned feature subgroups may help further 
clarify features most helpful in TB diagnosis, and assist in minimising inconclusive studies 
going further. 
4.4. Future applications  
Further development and study of explicit criteria for the detection of the various feature 
groups, especially that of lymphadenopathy may improve the sensitivity and specificity 
and thus the clinical value, of CXR in the diagnosis of TB in children. 
Comparison with CT as the gold standard would also help develop and validate such 
criteria. 
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5. Conclusion 
Our study demonstrated similar findings to prior publications with lymphadenopathy the 
most common extra-parenchymal finding on CXR in paediatric TB. Of interest, however is 
the lack of a significant difference in the frequency of lymphadenopathy in TB when 
comparing ambulatory and hospitalised patients. Parenchymal changes, while showing 
the expected increase in frequency in the hospitalised group, are unfortunately relatively 
non-specific for TB as shown by the concomitant increase in parenchymal change in the 
control group. Combined with other features however there was a slight, but statistically 
insignificant, higher percentage of patients in the hospitalised group diagnosed with TB 
on CXR. Exploration and comparison of the subtypes of parenchymal change seen in TB, 
compared with those found in non tuberculous infection, is outside of the scope of this 
study, but may be of value for future study. 
 
Pleural effusions were relatively common in our study compared with previous literature, 
the reason for which is uncertain, but may relate to co-infection with other pathogens or 
indicate a larger than known role of pleural effusion in the differentiation between 
paediatric pneumonia and TB, and warrants further study. 
 
Our study, like previous literature showed poor inter-observer agreement, particularly 
when considering our least ‘expert’ reader, and this raises concerns about the use of CXR 
in a clinic setting where the interpreting doctors are likely to be relatively junior, with less 
paediatric experience than any of our readers. However, when considering only two 
readers the inter-observer agreement trended toward being higher for the ambulatory 
group for lymphadenopathy and overall CXR diagnosis of PTB. This is contrary to our 
initial hypothesis and may indicate that the more severe parenchymal changes in the 
hospitalised group could obscure more specific findings of TB.  
 
This highlights the need for the development and study of explicit criteria, in particular for 
the presence of lymphadenopathy, and also for those parenchymal changes more specific 
for TB, in order to improve the diagnostic value of CXR for paediatric TB in all settings. 
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